- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05740839
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study (HYPE)
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study (HYPE)
The purpose of this study is to determine whether a 16-week virtual, home-based, high-intensity interval training (HIIT) exercise program will improve physical, cognitive, and emotional health among young adult survivors of pediatric brain tumors.
The names of the study interventions involved in this study are/is:
- High-Intensity Interval Training (HIIT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a Pilot/Feasibility, randomized control, research study that will compare an exercise group to a control group on physical, social, and overall quality of life needs of pediatric brain tumor survivors who are now young adults.
Participants will be randomized (selected at random) for two groups: HIIT program group will complete a 16-week intervention period followed by a 16-week period with no intervention and the waitlisted control group will complete a 16-week period and will perform their usual, daily activities followed by an optional 16-week period in which they can complete the HIIT program.
Research procedures include screening for eligibility, study treatment including in-clinic evaluations of fitness and strength, blood collection, at-home zoom exercise sessions, self-administered activity logs, and survey questionnaires.
Participation in this research study is expected to last about 8 months.
It is expected that about 30 people will take part in this research study.
The Stahl Family Charitable Foundation, Pedal 4 Pediatrics, and the Childhood Brain Tumor Foundation are supporting this research study by providing funding for the study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christina Dieli-Conwright, PhD, MPH
- Phone Number: 617-582-8321
- Email: ChristinaM_Dieli-Conwright@DFCI.HARVARD.EDU
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Recruiting
- Dana Farber Cancer Institute
-
Contact:
- Christina M Dieli-Conwright, PhD, MPH
- Phone Number: 617-632-3800
- Email: ChristinaM_Dieli-Conwright@dfci.harvard.edu
-
Contact:
- PhD, MPH
-
Principal Investigator:
- Christina M Dieli-Conwright, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Written informed consent prior to any study-related procedures.
- At time of study are a young adult, aged 18-39 years.
- Histologically diagnosed brain tumor during childhood (diagnosed ≤18 years).
- Are at least 2 years post tumor-directed therapy.
- The effects of exercise on the developing fetus are unknown. For this reason, women of child-bearing potential must agree to undergo a pregnancy test and to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for six months following duration of study participation. Should a woman become pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately.
- Medically cleared to participate in exercise by their referred physician or a certified clinical exercise physiologist.
- Are without medical conditions that could exacerbate with exercise, such as bone disease (excluding bone metastases) at imminent risk of fracture or uncontrolled cardiopulmonary or metabolic diseases.
- Speak English and/or Spanish.
- Currently participate in less than or equal to 60 minutes of moderate or vigorous structured exercise/week.
- Does not smoke or vape (no smoking/vaping during previous 12 months).
- Willing to travel to DFCI for necessary data collection.
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
- Diagnosis of primary spinal cord tumor.
- Pre-existing medical conditions such as uncontrolled cardiopulmonary disease, or metabolic diseases that could exacerbate with exercise.
- Patients with active malignancies.
- Patients who are pregnant.
- Actively on a weight loss diet.
- Participate in more than 60 minutes of moderate or vigorous structured exercise/week.
- Currently smokes or vapes.
- Unable to travel to DFCI for necessary data collection.
- May not be able to comply with the safety monitoring requirements of the study in the opinion of the investigator.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: HIIT Exercise Program Group
Participants will be randomly assigned to the HIIT exercise group and receive:
|
Exercise program with stationary bike via the Zoom platform.
Other Names:
|
Active Comparator: Control Group
Participants will be randomly assigned to the HIIT waitlist control group and receive:
|
Usual Activities
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attendance of Exercise Sessions
Time Frame: From first exercise session to final exercise session, up to 16 weeks
|
Defined as participant attendance of >= 70% of the 48 HIIT exercise sessions.
|
From first exercise session to final exercise session, up to 16 weeks
|
Completion in Minutes of Exercise Sessions
Time Frame: From first exercise session to final exercise session, up to 16 weeks
|
Defined as participant completion of >= 70% of the 90 minutes of exercise per week
|
From first exercise session to final exercise session, up to 16 weeks
|
HIIT Compliance
Time Frame: From first exercise session to final exercise session, up to 16 weeks
|
Defined as obtaining +-5W of target power output for >= 40 seconds of high intensity minute
|
From first exercise session to final exercise session, up to 16 weeks
|
Barriers to Exercise Adherence
Time Frame: From first exercise session to final exercise session, up to 16 weeks
|
Assessed through the 17-item Barriers to Recruitment Participation Questionnaire (BRPQ), 1-5 scale with 1 denoted as strongly agree and 5 as strongly disagree.
|
From first exercise session to final exercise session, up to 16 weeks
|
Participant Burden
Time Frame: From first exercise session to final exercise session, up to 16 weeks
|
Assessed through the Perceived Research Burden Assessment (PRBA), 1-5 scale with 1 denoted as strongly disagree and 5 as strongly agree.
|
From first exercise session to final exercise session, up to 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognition
Time Frame: : From baseline to post-intervention, up to 43 weeks
|
An assortment of tests will be executed through the NIH toolbox to measure overall cognition.
|
: From baseline to post-intervention, up to 43 weeks
|
Cardiorespiratory Fitness
Time Frame: From baseline to post-intervention, up to 43 weeks
|
Assessed through the use of a VO2 max (or submaximal if equipment is unavailable) cycle exercise stress test (Parvo Medics TrueOne 2400; Sandy, UT, USA).
|
From baseline to post-intervention, up to 43 weeks
|
Muscular Strength
Time Frame: From baseline to post-intervention, up to 43 weeks
|
10-repetition maximum will be used to assess muscular strength.
|
From baseline to post-intervention, up to 43 weeks
|
Body Composition
Time Frame: From baseline to post-intervention, up to 43 weeks
|
Bioelectrical Impedance Analysis (BIA), and blood pressure as measured twice on both arms with a seated position with a minimum of 1-minute interval and the higher pressure will be recorded when there are differences. BIA: Assessed via bioelectrical impedance using a validated device (Tanita 780, Arlington Heights, IL). Participants will be asked to remove their shoes and socks after which height will be taken using a stadiometer they will then proceed to move to the BIA and stand still on the device while holding the handles with their hands at their sides. The device will estimate body fat using an algorithm based on their age, sex, height, and body weight. |
From baseline to post-intervention, up to 43 weeks
|
Fatigue
Time Frame: From baseline to post-intervention, up to 43 weeks
|
BFI: A questionnaire of scale ratings 0 - 10 that focuses on cancer-related fatigue and tiredness.
|
From baseline to post-intervention, up to 43 weeks
|
Psychosocial Health
Time Frame: From baseline to post-intervention, up to 43 weeks
|
Assessed through the Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire, which is comprised of 27 items with scale ratings validated to measure physical, emotional, social, and functional well-being of cancer patients and survivors
|
From baseline to post-intervention, up to 43 weeks
|
Quality of Sleep
Time Frame: From baseline to post-intervention, up to 43 weeks
|
Assessed through the Pittsburg Sleep Quality Index (PSQI), which is used to measure 7 components of the quality and patterns of sleep in participants.
|
From baseline to post-intervention, up to 43 weeks
|
Dietary Assessment, ASA-24
Time Frame: Up to 3 days
|
Participants will be provided with a login to enter dietary data measured by an automated, online self-administered 24-hour assessment tool.
|
Up to 3 days
|
ActiGraph - Physical Activity Monitoring
Time Frame: From baseline to post-intervention, up to 27 weeks
|
Participants will be provided with an accelerometer (ActiGraph, Pensacola, FL) to wear for seven days at baseline and post-intervention testing visits and will be instructed to wear the water-resistant accelerometer at all times except for when swimming or bathing.
The device will record activity data and will be electronically transferred to a computer via USB cable at time of completion.
|
From baseline to post-intervention, up to 27 weeks
|
Exercise Tolerance
Time Frame: From baseline to week 16, up to 32 weeks
|
Will be recorded using the Exercise-Induced Feeling Inventory (EIF).
Based on a 0-4 scale, it assesses the participant's feeling state change(s) post-exercise and is also used for the assessment of self-motivation to adhere to an exercise regimen.
Participants will be asked to complete the inventory before and after each exercise session.
|
From baseline to week 16, up to 32 weeks
|
Pain Index
Time Frame: From baseline to post-intervention, up to 43 weeks
|
BPI: A 9 item questionnaire to evaluate the severity of pain and the impact of pain on the participant's daily functioning.
|
From baseline to post-intervention, up to 43 weeks
|
Hip and Waist Circumference
Time Frame: From baseline to post-intervention, up to 43 weeks
|
Hip and waist circumference will be assessed and recorded in cm.
|
From baseline to post-intervention, up to 43 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christina Dieli-Conwright, PhD, MPH, Dana-Farber Cancer Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-505
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Brain Tumor
-
TC Erciyes UniversityCompletedPediatric Cancer | Pediatric Brain Tumor | Pediatric Solid TumorTurkey
-
St. Jude Children's Research HospitalAmerican Cancer Society, Inc.RecruitingSolid Tumor, Childhood | Brain Tumor, PediatricUnited States
-
Sabine Mueller, MD, PhDWashington University School of Medicine; Nationwide Children's Hospital; Rally...Not yet recruitingPediatric Brain Tumor | Recurrent Pediatric Brain Tumor | Pediatric Supratentorial NeoplasmUnited States
-
University of Alabama at BirminghamTerminated
-
University of California, San FranciscoCompletedPediatric Brain TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterColumbia University; University of Washington; University of Texas; Rutgers UniversityActive, not recruitingBrain Tumor | Pediatric Cancer | Pediatric Brain TumorUnited States
-
Aga Khan UniversityJinnah Postgraduate Medical CentreRecruitingNeurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients (PBT)Blood Cancer | Brain Tumor, PediatricPakistan
-
Samsung Medical CenterMinistry of Health, Republic of KoreaNot yet recruitingRelapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
Washington University School of MedicineNot yet recruitingBrain Tumor, PrimaryUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...CNOG-MC001 Collaborative GroupCompletedPediatric Brain Tumor | Malignant Brain Tumor | Tumors, Central Nervous System | Benign Brain TumorChina
Clinical Trials on HIIT Exercise Program
-
Hull University Teaching Hospitals NHS TrustTerminated
-
University of ValenciaCompleted
-
University of Kansas Medical CenterRecruiting
-
Universidade Federal do Rio de JaneiroUnknown
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
University of MiamiCompleted
-
University of Dublin, Trinity CollegeHealth Research Board, Ireland; Irish Cancer SocietyRecruitingPostoperative Complications | Physical Activity | Surgery--ComplicationsIreland
-
Diakonhjemmet HospitalThe Dam Foundation; The Norwegian Rheumatism Association; Norwegian Health AssociationCompletedRheumatoid Arthritis | Psoriatic Arthritis | SpondyloarthritisNorway
-
Universität Duisburg-EssenRecruiting
-
University of OstravaCompletedObesity | Diet ModificationCzechia